We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Dover's (DOV) Arm Inks Deal to Expand Software Solution Offerings
Read MoreHide Full Article
Dover Corporation (DOV - Free Report) has entered into an agreement with EdgePetrol Limited to acquire minority interest in a bid to expand its software solutions services to the global retail industry.
Based in London, EdgePetrol provides an innovative cloud-based software solution for management of revenues and operating results to the retail fueling industry. This secure and comprehensive solution operates in the Amazon Web Service (AWS) and complements Dover Fueling Solutions ("DFS"). DFS provides devices which assist in managing the flow of underlying data, while helping customers improve their business operations. Besides retail fueling, this software solution will provide DFS with growth scope in renewable energy for transportation and various other retail verticals. Notably, the latest agreement supports DFS’ goal of expanding its business through strategic partnerships, and broadening the solutions and products portfolio.
Dover has a long tradition of making successful acquisitions in diverse end markets. In fourth-quarter 2020, the company acquired Innovation Control Systems (ICS) in a bid to expand its offerings in the growing vehicle wash market. Last September, the company acquired XanTec in an effort to expand its automation solutions offering for polymer processing machines. In 2019, the company acquired three businesses for a total consideration of $216.4 million. Dover made these acquisitions to complement and expand upon the existing operations within the Fueling Solutions and Pumps & Process Solutions segments.
Given the improving market conditions and a robust demand backlog in the current year, Dover projects adjusted earnings per share between $6.25 and $6.45 for 2021. Revenue growth is estimated to be 8-10% (5-6% on an organic basis) for the full year. Moreover, the company is poised to gain from growth in biopharma, aerospace & defense, heat exchangers, food retail and marking & coding business for the current year.
Dover will gain from product digitization, e-commerce, new product development, and inorganic investment in core business platforms. The company’s productivity and cost-control initiatives continue to drive its top-line growth. Apart from this, Dover’s restructuring programs will support its margins.
Price Performance
The company’s shares have appreciated 64.7% over the past year compared with the industry’s rally of 201.9%.
Other similarly-ranked stocks in the Industrial Products sector are Deere & Co. (DE - Free Report) , AGCO Corporation (AGCO - Free Report) and Avery Dennison Corporation (AVY - Free Report) .
Deere has a projected earnings growth rate of 82.5% for fiscal 2021. Over the past year, the company’s shares have appreciated 133.2%.
AGCO has an estimated earnings growth rate of 29.9% for the ongoing year. The company’s shares have surged 134.1% in the past year.
Avery Dennison has an expected earnings growth rate of 11.8% for 2021. The stock has gained 79.2% in a year’s time.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better. See these 7 breakthrough stocks now>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Dover's (DOV) Arm Inks Deal to Expand Software Solution Offerings
Dover Corporation (DOV - Free Report) has entered into an agreement with EdgePetrol Limited to acquire minority interest in a bid to expand its software solutions services to the global retail industry.
Based in London, EdgePetrol provides an innovative cloud-based software solution for management of revenues and operating results to the retail fueling industry. This secure and comprehensive solution operates in the Amazon Web Service (AWS) and complements Dover Fueling Solutions ("DFS"). DFS provides devices which assist in managing the flow of underlying data, while helping customers improve their business operations. Besides retail fueling, this software solution will provide DFS with growth scope in renewable energy for transportation and various other retail verticals. Notably, the latest agreement supports DFS’ goal of expanding its business through strategic partnerships, and broadening the solutions and products portfolio.
Dover has a long tradition of making successful acquisitions in diverse end markets. In fourth-quarter 2020, the company acquired Innovation Control Systems (ICS) in a bid to expand its offerings in the growing vehicle wash market. Last September, the company acquired XanTec in an effort to expand its automation solutions offering for polymer processing machines. In 2019, the company acquired three businesses for a total consideration of $216.4 million. Dover made these acquisitions to complement and expand upon the existing operations within the Fueling Solutions and Pumps & Process Solutions segments.
Given the improving market conditions and a robust demand backlog in the current year, Dover projects adjusted earnings per share between $6.25 and $6.45 for 2021. Revenue growth is estimated to be 8-10% (5-6% on an organic basis) for the full year. Moreover, the company is poised to gain from growth in biopharma, aerospace & defense, heat exchangers, food retail and marking & coding business for the current year.
Dover will gain from product digitization, e-commerce, new product development, and inorganic investment in core business platforms. The company’s productivity and cost-control initiatives continue to drive its top-line growth. Apart from this, Dover’s restructuring programs will support its margins.
Price Performance
The company’s shares have appreciated 64.7% over the past year compared with the industry’s rally of 201.9%.
Zacks Rank & Other Stocks to Consider
Dover currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Other similarly-ranked stocks in the Industrial Products sector are Deere & Co. (DE - Free Report) , AGCO Corporation (AGCO - Free Report) and Avery Dennison Corporation (AVY - Free Report) .
Deere has a projected earnings growth rate of 82.5% for fiscal 2021. Over the past year, the company’s shares have appreciated 133.2%.
AGCO has an estimated earnings growth rate of 29.9% for the ongoing year. The company’s shares have surged 134.1% in the past year.
Avery Dennison has an expected earnings growth rate of 11.8% for 2021. The stock has gained 79.2% in a year’s time.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>